HF
NMTC icon

HRT Financial’s NeuroOne Medical Technologies NMTC Stock Holding History

HRT Financial’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,364
Closed -$13K – 3412
2025
Q2 		$13K Buy
+3,364
New +$12.4K ﹤0.01% 2435
2025
Q1 		– Sell
-2,108
Closed -$10K – 3107
2024
Q4 		$10K Buy
+2,108
New +$10.5K ﹤0.01% 2282
2022
Q1 		– Sell
-2,147
Closed -$24K – 3613
2021
Q4 		$24K Sell
2,147
-4,382
-67% -$70.9K ﹤0.01% 2927
2021
Q3 		$154K Buy
+6,529
New +$187K ﹤0.01% 2776

Other funds holding NMTC

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

HRT Financial's NMTC Position: Q3 2025 in Review

HRT Financial sold out of NeuroOne Medical Technologies (NMTC) in Q3 2025, closing a stake of 3,364 shares — an estimated $13K sold.

HRT Financial first reported a position in NMTC in Q3 2021 and held it in 4 quarters. The position peaked at $154K in Q3 2021. 34 funds tracked by Wall St. Rank hold NMTC as of Q3 2025.

  • HRT Financial reported no remaining NeuroOne Medical Technologies position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 3,364 NeuroOne Medical Technologies shares in Q3 2025, an estimated $13K.
  • HRT Financial first reported a position in NeuroOne Medical Technologies in Q3 2021 and held it in 4 quarters.
  • HRT Financial's NeuroOne Medical Technologies position peaked at $154K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.